Misoprostol compared to oxytocin for postpartum hemorrhage
DOI:
https://doi.org/10.17267/2675-021Xevidence.2021.e3733Palavras-chave:
Postpartum hemorrhage. Oxytocin. Misoprostol. Uterotonics. Obstetrics.Downloads
Referências
Gallos ID, Papadopoulou A, Man R, Athanasopoulos N, Tobias A, Price MJ, et al. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2018;12:CD011689. https://doi.org/10.1002/14651858.cd011689.pub2
Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323-333. https://doi.org/10.1016/s2214-109x(14)70227-x
World Health Organization. WHO recommendations: Uterotonics for the prevention of postpartum haemorrhage [Internet]. Geneva: World Health Organization; 2018. Available from: https://apps.who.int/iris/bitstream/handle/10665/277276/9789241550420-eng.pdf?ua=1
Committee on Practice Bulletins-Obstetrics. Practice Bulletin No. 183: Postpartum Hemorrhage. Obstet Gynecol. 2017;130(4):e168-e186. https://doi.org/10.1097/aog.0000000000002351
Tunçalp Ö, Hofmeyr GJ, Gülmezoglu AM. Prostaglandins for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2012;(8):CD000494. https://doi.org/10.1002/14651858.cd000494.pub4
Smith WRP, Papadopoulou A, Thomas E, Tobias A, Price MJ, Meher S, et al. Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2020;11:CD012754. https://doi.org/10.1002/14651858.cd012754.pub2
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2021 Brit Long, Michael Gottlieb
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
The authors retain copyrights, transferring to the Journal of Evidence-Based Healthcare only the right of first publication. This work is licensed under a Creative Commons Attribution 4.0 International License.
